|
Receptor pharmacology
Citations 71-80 of 142 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Protease-Activated Receptor 2-Mediated Vasodilatation in Humans In Vivo. Role of Nitric Oxide and Prostanoids
- Jonathan Robin, Rajesh Kharbanda, Peter Mclean, Richard Campbell, and Patrick Vallance
Circulation published February 10, 2003, doi:10.1161/01.CIR.0000050620.37260.75
[Abstract]
- Special Review: Clinical Cardiology: New Frontiers
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises: Part III: Cellular and Molecular Clues to Heart and Arterial Aging
- Edward G. Lakatta
Circulation 2003;107:490-497, doi:10.1161/01.CIR.0000048894.99865.02
[Full text]
- Clinical Investigations and Reports
Effects of Selective  1- and 2-Adrenergic Blockade on Coronary Flow Reserve After Coronary Stenting
- Luisa Gregorini, Jean Marco, Bruno Farah, Monique Bernies, Carlo Palombo, Michaela Kozàkovà, Irene M. Bossi, Bernard Cassagneau, Jean Fajadet, Carlo Di Mario, Remo Albiero, Massimo Cugno, Adalberto Grossi, and Gerd Heusch
Circulation 2002;106:2901-2907; published online before print as doi:10.1161/01.CIR.0000040998.88272.A7
[Abstract]
[Full text]
- Articles
Effects of Selective  1- and 2-Adrenergic Blockade on Coronary Flow Reserve After Coronary Stenting
- Luisa Gregorini, Jean Marco, Bruno Farah, Monique Bernies, Carlo Palombo, Michaela Kozàkovà, Irene M. Bossi, Bernard Cassagneau, Jean Fajadet, Carlo Di Mario, Remo Albiero, Massimo Cugno, Adalberto Grossi, and Gerd Heusch
Circulation published November 11, 2002, doi:10.1161/01.CIR.0000040998.88272.A7
[Abstract]
- Clinical Investigations and Reports
Specific ß2AR Blocker ICI 118,551 Actively Decreases Contraction Through a Gi-Coupled Form of the ß2AR in Myocytes From Failing Human Heart
- Haibin Gong, Hong Sun, Walter J. Koch, Thomas Rau, Thomas Eschenhagen, Ursula Ravens, Jürgen F. Heubach, Dawn L. Adamson, and Sian E. Harding
Circulation 2002;105:2497-2503; published online before print as doi:10.1161/01.CIR.0000017187.61348.95
[Abstract]
[Full text]
- Basic Science Reports
Bucindolol Displays Intrinsic Sympathomimetic Activity in Human Myocardium
- Peter Andreka, Nambi Aiyar, Leslie C. Olson, Jian Qin Wei, Mark S. Turner, Keith A. Webster, Eliot H. Ohlstein, and Nanette H. Bishopric
Circulation 2002;105:2429-2434; published online before print as doi:10.1161/01.CIR.0000016050.79810.18
[Abstract]
[Full text]
- Clinical Investigations and Reports
Specific ß2AR Blocker ICI
118,551 Actively Decreases Contraction Through a
Gi-Coupled Form of the
ß2AR in Myocytes From Failing Human
Heart
- Haibin Gong, Hong Sun, Walter J. Koch, Thomas Rau, Thomas Eschenhagen, Ursula Ravens, Jürgen F. Heubach, Dawn L. Adamson, and Sian E. Harding
Circulation published May 6, 2002, doi:10.1161/01.CIR.0000017187.61348.95
[Abstract]
- Articles
Bucindolol Displays Intrinsic Sympathomimetic
Activity in Human Myocardium
- Peter Andreka, Nambi Aiyar, Leslie C. Olson, Jian Qin Wei, Mark S. Turner, Keith A. Webster, Eliot H. Ohlstein, and Nanette H. Bishopric
Circulation published May 6, 2002, doi:10.1161/01.CIR.0000016050.79810.18
[Abstract]
- Clinical Investigations and Reports
BG9719 (CVT-124), an A1 Adenosine Receptor Antagonist, Protects Against the Decline in Renal Function Observed With Diuretic Therapy
- Stephen S. Gottlieb, D. Craig Brater, Ignatius Thomas, Edward Havranek, Robert Bourge, Steven Goldman, Farere Dyer, Miguel Gomez, Donald Bennett, Barry Ticho, Evan Beckman, and William T. Abraham
Circulation 2002;105:1348-1353; published online before print as doi:10.1161/hc1102.105264
[Abstract]
[Full text]
- Articles
BG9719 (CVT-124), an A1
Adenosine Receptor Antagonist, Protects Against the
Decline in Renal Function Observed With Diuretic
Therapy
- Stephen S. Gottlieb, D. Craig Brater, Ignatius Thomas, Edward Havranek, Robert Bourge, Steven Goldman, Farere Dyer, Miguel Gomez, Donald Bennett, Barry Ticho, Evan Beckman, and William T. Abraham
Circulation published February 25, 2002, doi:10.1161/hc1102.105264
[Abstract]
|
|
